Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.

Gulick RM, Lalama CM, Ribaudo HJ, Shikuma CM, Schackman BR, Schouten J, Squires KE, Koletar SL, Pilcher CD, Reichman RC, Klingman KL, Kuritzkes DR. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS. 2007 Apr 23; 21(7):813-23.

View in: PubMed

subject areas

Adenine
Adult
Aged
Alkynes
Anti-HIV Agents
Antiretroviral Therapy, Highly Active
Benzoxazines
CD4 Lymphocyte Count
Cyclopropanes
Drug Resistance, Viral
Female
Genotype
HIV Infections
HIV-1
Humans
Male
Middle Aged
Patient Compliance
Reverse Transcriptase Inhibitors
RNA, Viral
Treatment Outcome
Viral Load

authors with profiles

Cecilia M. Shikuma,MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support